NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Jyothy Labs Ltd. Q4 Research Report

Overview

Jyothy Labs Ltd. (JLL) is an Indian FMCG player with a diverse product portfolio across fabric care, dishwashing, mosquito repellents, and personal care. The company's revenue grew by approximately 5% YoY, driven by a 7% YoY increase in volumes. However, EBITDA and PAT declined by 4% and 7% respectively due to softness in margins.

Segmental Performance

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

  • Fabric Care revenue grew by 9% YoY, led by strong liquid detergents.
  • Dishwash revenue declined by 1.3% YoY despite a 7% YoY increase in volumes due to high competitive intensity.
  • Personal Care and Household Insecticides (HI) grew by 11% and 13% YoY respectively.

Key Metrics

  • Gross margin declined by 330bps YoY to 46.5% due to price cuts and higher grammage in key categories.
  • EBITDA margins dropped by 140bps YoY to 15%.
  • Ad-spend for the quarter was approximately 7.7% of sales, with a guided range of 8-9% for a broader time horizon.

Financial Position

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

  • The company maintains a strong cash position of approximately Rs. 800 crore and remains debt-free, supporting future growth and potential acquisitions.

Valuation and Recommendation

  • The stock currently trades at a 1yr fwd PE of 24x (30x 5yr avg).
  • We value JLL at a P/E of 22x (3yr avg=34x), with a target price of Rs. 271.
  • We recommend a BUY rating, supported by an improving demand outlook and a decent correction in valuation.

Investor Takeaway

Investors should note the company's revenue growth and cash position, but also consider the decline in EBITDA and PAT margins.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.